A study of nearly 15,000 Swedish adults published in Nature Medicine in March 2026 shows that certain antibiotics disrupt gut flora for up to eight years. Researchers from Uppsala University analyzed stool samples and prescription data to track the long-term impact of these medications on the microbiome.
Some antibiotics reduce bacterial diversity for eight years
The research team found that the bacterial diversity in the gut remains significantly reduced years after a patient completes a course of specific antibiotics. Lead author Gabriel Baldanzi stated that the footprint of these drugs stays visible long after the original infection has cleared. This contradicts previous assumptions that the microbiome restores itself within weeks or months.
The study highlights a persistent state of dysbiosis, which is an imbalance in the microbial community. This condition doesn’t resolve quickly for all patients. The data suggests that the biological recovery process is non-linear, with the most significant restoration occurring in the first two years before the process slows down considerably.
Specific drug classes increase chronic disease risks
Clindamycin, fluorquinolones, and flucloxacillin caused the most severe and lasting changes to the gut flora. A single Clindamycin therapy in the year before sampling was associated with the loss of approximately 47 bacterial species. These changes often involve an increase in bacteria linked to higher blood fat levels and a higher body-mass index.
These microbial shifts may heighten the risk of developing chronic conditions. The study connects this long-term imbalance to an increased likelihood of Type-2 diabetes, obesity, and cardiovascular diseases. The findings prompt a re-evaluation of the long-term risk-benefit profile of these specific drug classes.
Recovery patterns suggest a need for new therapies
Current medical approaches often overlook the slow pace of microbial recovery. Because the gut doesn’t always return to its original state, researchers are looking for ways to actively restore balance. This shift in focus could change how doctors manage patients after antibiotic treatment.
Medical interest is growing in the use of phytotherapy and Traditional Chinese Medicine to help rebuild the microbiome. These fields are now primary areas of research for developing strategies to counteract the long-term damage caused by antibacterial drugs.
Which antibiotics cause the most long-term damage?
The most significant long-term effects were observed with clindamycin, fluorquinolones, and flucloxacillin, where changes persisted for four to eight years.
What health risks are associated with these changes?
The resulting dysbiosis is linked to an increased risk of cardiovascular diseases, obesity, and Type-2 diabetes, often coinciding with higher blood fat levels and BMI.
Weiterlesen
